Justyna Kelly
Chief Operating Officer bei POINT Biopharma, Inc. (United States)
Profil
Justyna Kelly is currently the VP-Medical Isotope Development & Operations at POINT Biopharma, Inc. She was previously the Chief Operating Officer at POINT Biopharma Global, Inc. from 2021 to 2023.
Ms. Kelly received her undergraduate and graduate degrees from McMaster University.
Aktive Positionen von Justyna Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Chief Operating Officer | - |
Ehemalige bekannte Positionen von Justyna Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| POIT BIOP | Chief Operating Officer | 27.12.2023 |
Ausbildung von Justyna Kelly
| McMaster University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Private Unternehmen | 1 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
